Humana sues Bayer, alleging $7.3B weedkiller settlement fails to reimburse insurers
Humana lodged a federal complaint Sept. 3 against Bayer AG and its acquired company, Monsanto, the business behind the weedkiller Roundup, seeking recoveries to address payments for Medicare Advantage members’ non-Hodgkin lymphoma-related care. Roundup’s active ingredient, glyphosate, has previously been linked to cancer risks. The lawsuit, filed in the U.S. District Court for the District […] The post Humana sues Bayer, alleging $7.3B weedkiller settlement fails to reimburse insurers appeare...
View related coverage on the timeline →
Useful signal?
Sign in with GitHub below to react 👍 / 👎, or comment if a category looks wrong — your reactions help curate this feed. How feedback works
Draft Insight Angle
Auto-generated draft — review and edit before any external use.
Humana — policy / regulatory changes. Via Becker's Payer Issues.
Analytic angles
- Compare against the current CMS rate/bid-cycle documents.
- Single-source so far — corroborate against a second outlet.
Draft paragraph
[DRAFT — verify before any external use] Becker's Payer Issues reports on policy / regulatory changes involving Humana: Humana lodged a federal complaint Sept. 3 against Bayer AG and its acquired company, Monsanto, the business behind the weedkiller Roundup, seeking recoveries to address payments for Medicare Advantage members’ non-Hodgki…
Note: This is an early signal based on public reporting. Confirm against primary sources before drawing conclusions. Market dynamics may shift as additional information emerges.